Strategic Investment Solutions’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Buy
2,899
+5
+0.2% +$585 0.09% 109
2026
Q1
$348K Buy
2,894
+6
+0.2% +$693 0.08% 114
2025
Q4
$304K Buy
2,888
+503
+21% +$47.2K 0.07% 114
2025
Q3
$200K Buy
2,385
+2
+0.1% +$165 0.05% 133
2025
Q2
$189K Buy
2,383
+207
+10% +$16.5K 0.06% 125
2025
Q1
$195K Buy
2,176
+2
+0.1% +$187 0.06% 106
2024
Q4
$216K Buy
2,174
+1
+0% +$103 0.07% 93
2024
Q3
$247K Buy
2,173
+17
+0.8% +$2.02K 0.07% 88
2024
Q2
$237K Buy
+2,156
New +$278K 0.08% 87
2023
Q4
$236K Sell
2,167
-132,774
-98% -$13.8M 0.04% 183
2023
Q3
$14.5M Buy
134,941
+132,800
+6,203% +$14.3M 0.18% 78
2023
Q2
$238K Sell
2,141
-189
-8% -$21.5K 0.05% 131
2023
Q1
$248K Hold
2,330
0.05% 159
2022
Q4
$241K Buy
+2,330
New +$238K 0.12% 84

Other funds holding MRK

Strategic Investment Solutions's MRK Position: Q2 2026 in Review

Strategic Investment Solutions increased its Merck (MRK) stake by 0.17% in Q2 2026, buying an estimated $585 and bringing the position to 2,899 shares worth $373K. The position accounts for 0.09% of the portfolio, ranked #109.

Strategic Investment Solutions first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $14.5M in Q3 2023. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Strategic Investment Solutions held 2,899 shares of Merck worth $373K as of Q2 2026.
  • Strategic Investment Solutions bought 5 Merck shares in Q2 2026, an estimated $585.
  • Merck made up 0.09% of Strategic Investment Solutions's portfolio in Q2 2026, its #109 holding.
  • Strategic Investment Solutions first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Strategic Investment Solutions's Merck position peaked at $14.5M in Q3 2023.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Strategic Investment Solutions's 13F filing for Q2 2026, filed 8 Jul 2026.